Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021
HomeTFS HealthScienceTFS HealthScience Standardizes on Veeva Vault Clinical Operations Suite to Accelerate Clinical...

TFS HealthScience Standardizes on Veeva Vault Clinical Operations Suite to Accelerate Clinical Development

March 25, 2021

TFS HealthScience will be the first CRO to have selected Veeva Vault Clinical Operations Suite for end-to-end study management on a single cloud platform.

The European-headquartered global CRO is taking action to further modernize the study operations, adopting the entire suite to drive greater efficiency and speed in trials. TFS HealthScience will now be offering its biopharma customers industry-leading technologies to improve patient safety whilst reducing the financial burden and increasing compliance.

“Veeva Vault Clinical Operations Suite gives us a foundation for further growth as we expand our service offering globally,” said Dr. Bassem Saleh, CEO, TFS HealthScience. “Bringing together study operations streamlines the processes, enabling us to maximize value for sponsors and accelerate the delivery of treatments to patients.”

TFS HealthScience provides strategic tailored solutions to its customers with a focus on driving excellence and innovation to reduce the complexity across study processes. Building on its success with Veeva Vault eTMF to maintain inspection readiness, the company will use Veeva Vault Study Startup to get studies up and running quickly, Veeva Vault CTMS to keep studies on track, and Veeva Vault Payments to simplify payments to global partner sites. With a connected, agile clinical landscape, TFS HealthScience will centralize governance and study oversight to share insights with sponsors easily.

“With Veeva Vault, we now have complete visibility into study progress and deviations to make better-informed decisions and ensure studies meet their objectives,” said Young Shon, CIO, TFS HealthScience. “Our partnership with Veeva is instrumental to TFS’s digital transformation program and our strategic push towards paperless and patient-centric approaches.”

TFS HealthScience is transforming clinical operations to work more efficiently and better serve sponsors,” said Pinar Benet, senior director strategy, Vault Clinical Operations at Veeva Systems. “We’re excited to continue this journey together towards unified and connected trials to accelerate clinical research.”

Veeva Vault Clinical Operations Suite enables sponsors and CROs to seamlessly share information and documents across CTMS, eTMF, study start-up, and payments for better collaboration and increased efficiency throughout the study lifecycle.

The Veeva Unified Clinical Operations Survey: Annual CRO Report shows that CROs like TFS HealthScience is moving to streamline trial execution by embracing new digital strategies and technologies that eliminate data silos and manual processes. Learn how CROs are modernizing clinical operations to speed trials in the full report, available here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy